Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Incidence and surgical management of secondary spine infections: A retrospective case series study of 4,921 consecutive patients.
Journal: Journal of clinical orthopaedics and trauma
Published: April 07, 2026
The Microbiology of Postoperative Spine Surgical Site Infections: An Institutional Experience of 170 cases.
Journal: Journal of clinical orthopaedics and trauma
Published: April 07, 2026
Clinical and Physiologically Based Pharmacokinetic Model Evaluations of Adagrasib Drug-Drug Interactions.
Journal: Clinical pharmacology and therapeutics
Published: August 16, 2024
Absorption, single-dose and steady-state metabolism, excretion, and pharmacokinetics of adagrasib, a KRASG12C inhibitor.
Journal: Cancer chemotherapy and pharmacology
Published: May 24, 2024
Aerodynamics-guided machine learning for design optimization of electric vehicles.
Journal: Communications engineering
Published: May 06, 2024
Concentration-QTc modeling of sitravatinib in patients with advanced solid malignancies.
Journal: Clinical and translational science
Published: January 17, 2024
A Systematic Approach to Revision Total Knee Arthroplasty.
Journal: Instructional course lectures
Published: December 19, 2022
Absorption, Metabolism, and Excretion, In Vitro Pharmacology, and Clinical Pharmacokinetics of Ozanimod, a Novel Sphingosine 1-Phosphate Receptor Modulator.
Journal: Drug metabolism and disposition: the biological fate of chemicals
Published: August 21, 2020
Concentration-QTc Modeling of Ozanimod's Major Active Metabolites in Adult Healthy Subjects.
Journal: CPT: pharmacometrics & systems pharmacology
Published: August 21, 2020
Multiple-Dose Pharmacokinetics of Ozanimod and its Major Active Metabolites and the Pharmacodynamic and Pharmacokinetic Interactions with Pseudoephedrine, a Sympathomimetic Agent, in Healthy Subjects.
Journal: Advances in therapy
Published: August 07, 2020
Expansion of immature, nucleated red blood cells by transient low-dose methotrexate immune tolerance induction in mice.
Journal: Clinical and experimental immunology
Published: July 20, 2020
Last Updated: 09/26/2026